What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).
D001557:Benzenesulfonates / Q000627:therapeutic use*; D002123:Calcium Dobesilate / Q000494:pharmacology / Q000627:therapeutic use*; D002198:Capillary Fragility / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000209:etiology; D006801:Humans
D001557:Benzenesulfonates; D002123:Calcium Dobesilate